Uganda National Health Products Traceability Strategy: Government Implements Strict Regulations

• The Government of Uganda has launched the National Health Products Traceability Strategy (NHPTS) to improve the safety and efficiency of health products.
• The NHPTS aims to track all health products from manufacturer to consumer, enabling quick identification and response to product recalls or quality issues.
• The strategy is built on existing laws and regulations governing health products in Uganda and aligns with international standards for pharmaceutical regulation.

The NHPTS has far-reaching implications for public health in Uganda by improving the safety and efficiency of health products, reducing the risk of counterfeit or substandard medicines entering the market.

The Government of Uganda has launched the National Health Products Traceability Strategy (NHPTS) to improve the safety and efficiency of health products in the country. The strategy aims to ensure that all health products, including medicines, vaccines, and medical devices, can be tracked from manufacturer to consumer. This will enable the government to quickly identify and respond to any product recalls or quality issues.

The NHPTS is a key component of Uganda's efforts to strengthen its healthcare system and improve access to safe and effective health products. The strategy has been developed in collaboration with various stakeholders, including the National Drug and Health Products Authority (NDHPA), the Ministry of Health, and other government agencies.

The NHPTS is built on existing laws and regulations governing the importation, distribution, and sale of health products in Uganda. The strategy aligns with the country's National Drug and Health Products Authority Act, 2026, which requires that all health products be registered and licensed before they can be sold or distributed in the country. The NHPTS also takes into account international standards for pharmaceutical regulation, including those set by the World Health Organization (WHO) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

The strategy is expected to have significant implications for pharmaceutical companies operating in Uganda, as it will require them to implement robust traceability systems and comply with strict regulations governing the importation, storage, and sale of health products.

The NHPTS has far-reaching implications for public health in Uganda. By improving the safety and efficiency of health products, the strategy is expected to reduce the risk of counterfeit or substandard medicines entering the market. This will not only protect consumers but also help to prevent the spread of diseases and improve treatment outcomes.

Furthermore, the NHPTS has significant potential to boost economic growth in Uganda by creating jobs and stimulating investment in the pharmaceutical sector. The strategy is expected to attract more foreign investment in the industry and promote local manufacturing of health products.

Lawyers should watch for the implications of this strategy on supply chain management and compliance for pharmaceutical companies operating in Uganda.

Source: Original reporting via Government of Uganda